Second-line Switch to Dolutegravir Study
Clinical trial NCT04229290 · COMPLETED
Trial details
- NCT number
- NCT04229290
- Sponsor
- University of Nairobi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-12
- Primary completion
- 2021-09-16
- Enrollment
- 795
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.